189 related articles for article (PubMed ID: 33429326)
1. The number of lymph nodes examined is associated with survival outcomes and nodal upstaging in patients with stage I small cell lung cancer.
Chen Y; Zhang J; Jiang C; Zhang H; Fan P; Yu H; Zhang H; Fei K; Zhang P
Surg Oncol; 2021 Jun; 37():101513. PubMed ID: 33429326
[TBL] [Abstract][Full Text] [Related]
2. Effect of Lymph Node Assessment on Outcomes in Surgery for Limited Stage Small Cell Lung Cancer.
Rucker AJ; Raman V; Jawitz OK; Voigt SL; Tong BC; D'Amico TA; Harpole DH
Ann Thorac Surg; 2020 Dec; 110(6):1854-1860. PubMed ID: 32544452
[TBL] [Abstract][Full Text] [Related]
3. Association of log odds of positive lymph nodes with survival in patients with small cell lung cancer: Results from the SEER database.
Gao T; Chang Y; Yue H
Clinics (Sao Paulo); 2024; 79():100369. PubMed ID: 38696974
[TBL] [Abstract][Full Text] [Related]
4. Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery.
Thomas DC; Arnold BN; Rosen JE; Salazar MC; Blasberg JD; Detterbeck FC; Boffa DJ; Kim AW
Lung Cancer; 2017 Jan; 103():75-81. PubMed ID: 28024700
[TBL] [Abstract][Full Text] [Related]
5. Disparities in the Management of Patients With Stage I Small Cell Lung Carcinoma (SCLC): A Surveillance, Epidemiology and End Results (SEER) Analysis.
Ahmed Z; Kujtan L; Kennedy KF; Davis JR; Subramanian J
Clin Lung Cancer; 2017 Sep; 18(5):e315-e325. PubMed ID: 28438510
[TBL] [Abstract][Full Text] [Related]
6. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer.
Licht PB; Jørgensen OD; Ladegaard L; Jakobsen E
Ann Thorac Surg; 2013 Sep; 96(3):943-9; discussion 949-50. PubMed ID: 23684159
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.
Yang H; Mei T
Eur J Cardiothorac Surg; 2021 Nov; 60(5):1212-1220. PubMed ID: 34195790
[TBL] [Abstract][Full Text] [Related]
8. Optimal Lymph Node Examination and Adjuvant Chemotherapy for Stage I Lung Cancer.
Dai J; Liu M; Yang Y; Li Q; Song N; Rocco G; Sihoe ADL; Gonzalez-Rivas D; Suen HC; He W; Duan L; Fan J; Zhao D; Wang H; Zhu Y; Chen C; Diasio RB; Jiang G; Yang P; Zhang P
J Thorac Oncol; 2019 Jul; 14(7):1277-1285. PubMed ID: 31009811
[TBL] [Abstract][Full Text] [Related]
9. Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?
Bott MJ; Patel AP; Crabtree TD; Colditz GA; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
Ann Thorac Surg; 2015 Dec; 100(6):2048-53. PubMed ID: 26277562
[TBL] [Abstract][Full Text] [Related]
10. Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases.
Qiao R; Zhong R; Xu J; Zhang Y; Zhang B; Wang S; Lou Y; Chen D; Chang Q; Zhao Y; Han B
J Cardiothorac Surg; 2019 Mar; 14(1):63. PubMed ID: 30925891
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Relevance of Negative Lymph Node Count in Resected Stage I-IIIa Small-cell Lung Cancer.
Yang H; Li D; Liu T
Am J Clin Oncol; 2023 Jul; 46(7):306-313. PubMed ID: 37102621
[TBL] [Abstract][Full Text] [Related]
12. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
[TBL] [Abstract][Full Text] [Related]
13. Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.
Xu L; Zhang G; Song S; Zheng Z
Medicine (Baltimore); 2019 Oct; 98(40):e17214. PubMed ID: 31577711
[TBL] [Abstract][Full Text] [Related]
14. Impact of Lymph Node Dissection on Survival and Tumor Recurrence for Patients with Resected cT1-2N0 Small Cell Lung Cancer.
Cheng X; Zeng W; Liu Y; Song Z; Han Y; Luo Q; Lu S
Ann Surg Oncol; 2022 Nov; 29(12):7512-7525. PubMed ID: 35904661
[TBL] [Abstract][Full Text] [Related]
15. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
[TBL] [Abstract][Full Text] [Related]
16. Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer.
Yu JB; Decker RH; Detterbeck FC; Wilson LD
J Thorac Oncol; 2010 Feb; 5(2):215-9. PubMed ID: 20101146
[TBL] [Abstract][Full Text] [Related]
17. Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital.
Gao L; Shen L; Wang K; Lu S
Lung Cancer; 2021 Dec; 162():54-60. PubMed ID: 34739854
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.
Zheng H; Gao W; Fei K; Xie HK; Jiang GN; Ding JA; Li C; Chen C; Zhang L
Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):447-54. PubMed ID: 23788199
[TBL] [Abstract][Full Text] [Related]
19. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition.
Ignatius Ou SH; Zell JA
J Thorac Oncol; 2009 Mar; 4(3):300-10. PubMed ID: 19156001
[TBL] [Abstract][Full Text] [Related]
20. A standardized technique of systematic mediastinal lymph node dissection by video-assisted thoracoscopic surgery (VATS) leads to a high rate of nodal upstaging in early-stage non-small cell lung cancer.
Reichert M; Steiner D; Kerber S; Bender J; Pösentrup B; Hecker A; Bodner J
Surg Endosc; 2016 Mar; 30(3):1119-25. PubMed ID: 26169635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
